Intercept Pharmaceuticals to Participate in B. Riley’s PBC Symposium on August 24, 2022
August 18 2022 - 7:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that the management team of Intercept will participate in
B. Riley’s PBC (Primary Biliary Cholangitis) Mini Symposium: Orphan
Liver Disease That May Not Be As Rare As You’d Think. This
PBC-focused event will take place virtually on Wednesday, August
24.
B. Riley will host a PBC panel with industry leaders and
physicians followed by analyst-moderated fireside chats with
participating companies. Industry leaders will discuss their
perspectives on the adoption and utilization of currently approved
first-line and second-line (1L and 2L) PBC therapies, as well as
the anticipated evolution of the treatment paradigm over the coming
years. The discussions will also focus on the field's latest
thinking on the mid-to-late-stage therapeutic pipeline, the state
of surrogate endpoints, and appropriate target product profiles
(TPPs) focused on driving patient-centric liver disease outcomes
and quality of life benefits. Intercept’s fireside chat is
scheduled for 1:00 p.m. ET.
Webcast DetailsThe event will be webcast live
starting at 11:00 a.m. ET on Wednesday, August 24. Intercept’s
fireside chat will begin at 1:00 p.m. ET. The webcast will be
available here and on the investor page of Intercept’s website at
http://ir.interceptpharma.com.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). For more information, please
visit www.interceptpharma.com or connect with the company
on Twitter and LinkedIn.
ContactFor more information about Intercept,
please contact:Investor
inquiries: investors@interceptpharma.comMedia
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024